Man who called 2020 Crash warns of huge event in 2022
A historic event in 2022 will cause a massive shift in the wealth divide. It could leave thousands of Americans under age 50 better off… while retirees will be left holding the scraps.
Details here…

TARS Insider Trading (Tarsus Pharmaceuticals)

Insider Ownership Percentage: 33.08%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $18,831,929.69

Tarsus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Tarsus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tarsus Pharmaceuticals Share Price & Price History

Current Price: $18.20
Price Change: Price Decrease of -0.73 (-3.86%)
As of 01/20/2022 01:00 AM ET

This chart shows the closing price history over time for TARS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!

Tarsus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2021D. Michael AckermannDirectorSell5,833$24.68$143,958.44View SEC Filing Icon  
11/8/2021Aziz MottiwalaInsiderSell1,889$28.11$53,099.79View SEC Filing Icon  
11/4/2021Aziz MottiwalaInsiderSell100$28.03$2,803.00View SEC Filing Icon  
11/2/2021Aziz MottiwalaInsiderSell6,000$26.78$160,680.00View SEC Filing Icon  
11/1/2021D. Michael AckermannDirectorSell5,833$27.82$162,274.06View SEC Filing Icon  
10/12/2021Bobak R. AzamianCEOSell5,531$26.30$145,465.30View SEC Filing Icon  
10/12/2021D. Michael AckermannDirectorSell5,633$26.27$147,978.91View SEC Filing Icon  
10/8/2021Bobak R. AzamianCEOSell302$25.02$7,556.04View SEC Filing Icon  
10/8/2021D. Michael AckermannDirectorSell200$25.03$5,006.00View SEC Filing Icon  
9/10/2021Aziz MottiwalaInsiderSell2,593$22.15$57,434.9558,203View SEC Filing Icon  
9/1/2021D. Michael AckermannDirectorSell5,833$25.24$147,224.921,221,515View SEC Filing Icon  
8/11/2021Bobak R. AzamianCEOSell1,917$25.07$48,059.191,750View SEC Filing Icon  
8/11/2021D. Michael AckermannDirectorSell621$25.15$15,618.151,227,348View SEC Filing Icon  
8/9/2021Bobak R. AzamianCEOSell827$25.02$20,691.541,750View SEC Filing Icon  
8/9/2021D. Michael AckermannDirectorSell700$25.00$17,500.00View SEC Filing Icon  
8/6/2021D. Michael AckermannDirectorSell3,129$25.00$78,225.00View SEC Filing Icon  
8/5/2021Bobak R. AzamianCEOSell1,370$25.00$34,250.00View SEC Filing Icon  
6/25/2021Vivo Capital Ix, LlcMajor ShareholderSell7,704$29.60$228,038.40View SEC Filing Icon  
6/23/2021Vivo Capital Ix, LlcMajor ShareholderSell37,980$29.80$1,131,804.00View SEC Filing Icon  
6/21/2021Vivo Capital Ix, LlcMajor ShareholderSell91,620$29.70$2,721,114.00View SEC Filing Icon  
5/7/2021Rtw Investments, LpMajor ShareholderSell450,000$29.98$13,491,000.00View SEC Filing Icon  
4/14/2021Vivo Capital Ix, LlcMajor ShareholderSell400$30.37$12,148.00View SEC Filing Icon  
10/20/2020Jason E TesterDirectorBuy171,875$16.00$2,750,000.00
10/20/2020Vivo Capital Fund Ix, L.P.Major ShareholderBuy250,000$16.00$4,000,000.00
See Full Table
Insider Selling at Tarsus Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Tarsus Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Tarsus Pharmaceuticals (NASDAQ:TARS)

62.26% of Tarsus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TARS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tarsus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/17/2021Jefferies Group LLC422,993$9.12M0.1%-4.5%2.046%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp24,523$0.53M0.0%+13.7%0.119%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System4,520$97K0.0%-61.2%0.022%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley28,530$0.62M0.0%+244.5%0.139%Search for SEC Filing on Google Icon
11/15/2021Invesco Ltd.28,614$0.62M0.0%-6.0%0.139%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC123,698$2.67M0.0%-1.5%0.601%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.26,480$0.57M0.0%-1.5%0.129%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.441,620$9.52M0.0%+0.7%2.147%Search for SEC Filing on Google Icon
11/8/2021TimesSquare Capital Management LLC650,780$14.02M0.1%-5.2%3.163%Search for SEC Filing on Google Icon
11/4/2021Sands Capital Ventures LLC260,000$5.60M0.8%N/A1.264%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund5,881$0.13M0.0%-37.1%0.029%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC46,253$1M0.0%+101.3%0.225%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley8,282$0.24M0.0%N/A0.040%Search for SEC Filing on Google Icon
8/20/2021Jefferies Group LLC442,993$12.84M0.1%N/A2.153%Search for SEC Filing on Google Icon
8/17/2021Invesco Ltd.30,428$0.88M0.0%+4.0%0.148%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE1,960$57K0.0%-78.8%0.010%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System11,644$0.34M0.0%+25.2%0.057%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley8,282$0.24M0.0%N/A0.040%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.46,573$1.35M0.0%+11.9%0.226%Search for SEC Filing on Google Icon
8/16/2021Jefferies Group LLC442,993$12.84M0.1%N/A2.153%Search for SEC Filing on Google Icon
8/16/2021State Street Corp119,141$3.45M0.0%+18.7%0.579%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC25,723$0.75M0.0%+73.4%0.125%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.26,880$0.78M0.0%-7.3%0.131%Search for SEC Filing on Google Icon
8/13/2021RTW Investments LP2,013,601$58.35M0.9%-18.3%9.787%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp79,635$2.31M0.0%+18.8%0.387%Search for SEC Filing on Google Icon
8/13/2021Altium Capital Management LP70,573$2.05M0.5%N/A0.343%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC125,521$3.64M0.0%+23.3%0.610%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.426,045$12.35M0.0%+56.1%2.071%Search for SEC Filing on Google Icon
8/12/2021SG Americas Securities LLC22,977$0.67M0.0%N/A0.112%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.5,162$0.15M0.0%-52.7%0.025%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp21,573$0.63M0.0%+39.4%0.105%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.438,356$12.70M0.0%+29.0%2.136%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG5,574$0.16M0.0%+41.6%0.027%Search for SEC Filing on Google Icon
8/11/2021Frazier Management LLC1,417,157$41.07M3.8%-26.1%6.905%Search for SEC Filing on Google Icon
8/11/2021Ghost Tree Capital LLC170,000$4.93M1.4%N/A0.828%Search for SEC Filing on Google Icon
8/10/2021Virtus ETF Advisers LLC6,319$0.18M0.1%N/A0.031%Search for SEC Filing on Google Icon
8/9/2021TimesSquare Capital Management LLC686,705$19.90M0.2%+52.0%3.346%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund9,353$0.27M0.0%+58.5%0.046%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC84,854$2.74M0.0%-41.2%0.413%Search for SEC Filing on Google Icon
5/17/2021Endurant Capital Management LP14,143$0.46M0.1%N/A0.069%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada1,470$48K0.0%+78.2%0.007%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP12,310$0.40M0.0%N/A0.060%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC14,832$0.48M0.0%+47.0%0.072%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.28,994$0.93M0.0%N/A0.141%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp15,474$0.50M0.0%-16.0%0.075%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp67,035$2.16M0.0%-4.8%0.324%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC101,809$3.28M0.0%-7.8%0.492%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.10,912$0.35M0.0%-35.0%0.053%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG2,496$80K0.0%+88.4%0.012%Search for SEC Filing on Google Icon
5/12/2021TimesSquare Capital Management LLC451,900$14.57M0.1%-2.7%2.183%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund5,900$0.19M0.0%+68.6%0.028%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.339,797$10.95M0.0%+5.4%1.641%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.16,783$0.69M0.0%N/A0.083%Search for SEC Filing on Google Icon
2/17/2021Sands Capital Management LLC260,000$10.75M0.0%N/A1.280%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC10,088$0.42M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.37,223$1.54M0.0%N/A0.183%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.3,574$0.15M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP20,000$0.83M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp70,399$2.91M0.0%N/A0.346%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.1,151$48K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/11/2021Frazier Management LLC1,917,157$79.24M6.1%N/A9.435%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN3,193$0.13M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp18,417$0.76M0.0%N/A0.091%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund3,500$0.15M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.322,423$13.33M0.0%N/A1.587%Search for SEC Filing on Google Icon
2/4/2021State of Wisconsin Investment Board8,600$0.36M0.0%N/A0.042%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tarsus Pharmaceuticals logo
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Read More on Tarsus Pharmaceuticals

Today's Range

Now: $18.20
Low: $16.87
High: $19.38

50 Day Range

MA: $24.39
Low: $18.20
High: $27.70

52 Week Range

Now: $18.20
Low: $16.87
High: $43.01

Volume

14,071 shs

Average Volume

20,098 shs

Market Capitalization

$376.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.59

Who are the company insiders with the largest holdings of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals' top insider shareholders include:
  1. Michael Ackermann (Director)
  2. Aziz Mottiwala (Insider)
  3. Bobak R Azamian (CEO)
  4. Jason E Tester (Director)
  5. Rtw Investments, Lp (Major Shareholder)
  6. Vivo Capital Fund Ix, LP (Major Shareholder)
  7. Vivo Capital Ix, Llc (Major Shareholder)
Buy Live Nation (LYV) Immediately
Wall Street legend who helped create America’s stock-rating system says this stock could soon be rated a “Strong Buy” at every bank in New York City and Boston. “It’s all part of the biggest prediction of my 50-year career on Wall Street,” he says. “A massive and surprising new transition that could determine the next group of millionaires.”
Click here to learn more.